Form 8-K - Current report:
SEC Accession No. 0001564590-21-035985
Filing Date
2021-07-07
Accepted
2021-07-07 16:05:36
Documents
12
Period of Report
2021-07-01
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K dvax-8k_20210701.htm   iXBRL 8-K 39139
  Complete submission text file 0001564590-21-035985.txt   170578

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA dvax-20210701.xsd EX-101.SCH 5772
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE dvax-20210701_lab.xml EX-101.LAB 19478
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dvax-20210701_pre.xml EX-101.PRE 11627
5 EXTRACTED XBRL INSTANCE DOCUMENT dvax-8k_20210701_htm.xml XML 3558
Mailing Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34207 | Film No.: 211077480
SIC: 2834 Pharmaceutical Preparations